Journal Guide

Biochemistry Molecular Biology

For more information, go to http://www.cell.com/trends/biochemical-sciences.

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

FinELibin ja Elsevierin sopimuksen perusteella vastaavat kirjoittajat voivat julkaista avoimia artikkeleita ilman APC-maksua (article processing charge) sopimuksen piiriin kuuluvissa Elsevierin Cell Press -lehdissä sopimusvuonna 2025. Julkaisuoikeus koskee hybridilehtiä. Avoimia artikkeleita on rajallinen määrä.
Under FinELib consortium’s agreement with Elsevier, corresponding authors can publish their articles open access without article processing charge (APC) in Cell Press hybrid journals eligible for the agreement during the agreement year 2025. There is a limited number of free open access articles available.

Ohjeita julkaisemiseen FinELibin sivuilla:

Artikkelin julkaiseminen avoimena Elsevierin Cell Press lehdissä

Open Access Publishing in Elsevier’s Cell Press Journals

Biotechnology Medicine (miscellaneous)

Publisher: Society for Biomaterials and Artificial Organs

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Publisher: Cell Press

Biotechnology Bioengineering

For more information, go to http://www.cell.com/trends/biotechnology.

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

FinELibin ja Elsevierin sopimuksen perusteella vastaavat kirjoittajat voivat julkaista avoimia artikkeleita ilman APC-maksua (article processing charge) sopimuksen piiriin kuuluvissa Elsevierin Cell Press -lehdissä sopimusvuonna 2025. Julkaisuoikeus koskee hybridilehtiä. Avoimia artikkeleita on rajallinen määrä.
Under FinELib consortium’s agreement with Elsevier, corresponding authors can publish their articles open access without article processing charge (APC) in Cell Press hybrid journals eligible for the agreement during the agreement year 2025. There is a limited number of free open access articles available.

Ohjeita julkaisemiseen FinELibin sivuilla:

Artikkelin julkaiseminen avoimena Elsevierin Cell Press lehdissä

Open Access Publishing in Elsevier’s Cell Press Journals

Publisher: Elsevier

Artikkelin julkaiseminen avoimena Elsevierin Cell Press lehdissä

Cancer Research Oncology

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

FinELibin ja Elsevierin sopimuksen perusteella vastaavat kirjoittajat voivat julkaista avoimia artikkeleita ilman APC-maksua (article processing charge) sopimuksen piiriin kuuluvissa Elsevierin Cell Press -lehdissä sopimusvuonna 2025. Julkaisuoikeus koskee hybridilehtiä. Avoimia artikkeleita on rajallinen määrä.
Under FinELib consortium’s agreement with Elsevier, corresponding authors can publish their articles open access without article processing charge (APC) in Cell Press hybrid journals eligible for the agreement during the agreement year 2025. There is a limited number of free open access articles available.

Ohjeita julkaisemiseen FinELibin sivuilla:

Open Access Publishing in Elsevier’s Cell Press Journals

Publisher: Cell Press

Artikkelin julkaiseminen avoimena Elsevierin Cell Press lehdissä

Cell Biology

For more information, go to http://www.cell.com/trends/cell-biology.

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

FinELibin ja Elsevierin sopimuksen perusteella vastaavat kirjoittajat voivat julkaista avoimia artikkeleita ilman APC-maksua (article processing charge) sopimuksen piiriin kuuluvissa Elsevierin Cell Press -lehdissä sopimusvuonna 2025. Julkaisuoikeus koskee hybridilehtiä. Avoimia artikkeleita on rajallinen määrä.
Under FinELib consortium’s agreement with Elsevier, corresponding authors can publish their articles open access without article processing charge (APC) in Cell Press hybrid journals eligible for the agreement during the agreement year 2025. There is a limited number of free open access articles available.

Ohjeita julkaisemiseen FinELibin sivuilla:

Open Access Publishing in Elsevier’s Cell Press Journals

Publisher: Cell Press

Endocrinology Endocrinology, Diabetes and Metabolism

For more information, go to http://www.cell.com/trends/endocrinology-metabolism

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

FinELibin ja Elsevierin sopimuksen perusteella vastaavat kirjoittajat voivat julkaista avoimia artikkeleita ilman APC-maksua (article processing charge) sopimuksen piiriin kuuluvissa Elsevierin Cell Press -lehdissä sopimusvuonna 2025. Julkaisuoikeus koskee hybridilehtiä. Avoimia artikkeleita on rajallinen määrä.
Under FinELib consortium’s agreement with Elsevier, corresponding authors can publish their articles open access without article processing charge (APC) in Cell Press hybrid journals eligible for the agreement during the agreement year 2025. There is a limited number of free open access articles available.

Ohjeita julkaisemiseen FinELibin sivuilla:

Artikkelin julkaiseminen avoimena Elsevierin Cell Press lehdissä

Open Access Publishing in Elsevier’s Cell Press Journals

Publisher: Elsevier

Food Science Biotechnology

Trends in Food Science & Technology is the only truly international peer-reviewed journal publishing critical reviews and viewpoints of current technology, food science and human nutrition. Its role is to fill the gap between the specialized primary journals and general trade magazines by focusing on the most promising new research developments and their current and potential food industry applications in a readable, scientifically rigorous way.Topics include new or novel raw materials including bioactive compounds, ingredients and technologies; molecular, micro- and macro-structure; new developments in food engineering; rapid techniques for online control; novel processing and packaging technologies; advanced biotechnological and nanoscience developments and applications in food research; quality assurance methods and application of -omics techniques; risk assessment of both biological and non-biological hazards in food; food allergies and intolerances; food function and relationships between diet and disease; and consumer attitudes to food and risk assessment.Issues include a selection of Reviews, Viewpoints, Conference Reports and Book Reviews, plus a calendar of upcoming conferences, courses and exhibitions. It does not publish research papers.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

FinELibin ja Elsevierin sopimuksen perusteella vastaavat kirjoittajat voivat julkaista avoimia artikkeleita ilman APC-maksua (article processing charge) sopimuksen piiriin kuuluvissa Elsevierin hybridi- ja hybrideistä gold open access -lehdiksi muuttuneissa lehdissä. Avoimia artikkeleita on sopimuskauden 2024-2025 aikana käytettävissä rajallinen määrä. Turun yliopisto tilaa myös sopimuksen ulkopuolisia lehtiä, joissa on mahdollista julkaista avoimena ilman kirjoittajamaksua. Lisätietoa osoitteesta kirjasto@utu.fi.
Under the agreement between FinELib and Elsevier, corresponding authors can publish open access articles without an APC (article processing charge) in eligible Elsevier hybrid journals and hybrid journals that have transitioned to gold open access. There is a limited number of free open access articles available during the agreement period 2024-2025. University of Turku also subscribes to some additional Elsevier journals that are not included in FinELib consortium agreement. For more information, contact library@utu.fi about publishing article open access without article processing charge (APC).

Ohjeita julkaisemiseen FinELibin sivuilla:

Artikkelin julkaiseminen avoimena Elsevierin lehdissä

Publisher: Cell Press

Artikkelin julkaiseminen avoimena Elsevierin Cell Press lehdissä

Genetics

For more information, go to http://www.cell.com/trends/genetics

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

FinELibin ja Elsevierin sopimuksen perusteella vastaavat kirjoittajat voivat julkaista avoimia artikkeleita ilman APC-maksua (article processing charge) sopimuksen piiriin kuuluvissa Elsevierin Cell Press -lehdissä sopimusvuonna 2025. Julkaisuoikeus koskee hybridilehtiä. Avoimia artikkeleita on rajallinen määrä.
Under FinELib consortium’s agreement with Elsevier, corresponding authors can publish their articles open access without article processing charge (APC) in Cell Press hybrid journals eligible for the agreement during the agreement year 2025. There is a limited number of free open access articles available.

Ohjeita julkaisemiseen FinELibin sivuilla:

Open Access Publishing in Elsevier’s Cell Press Journals

Biochemistry Organic Chemistry

Publisher: Gakushin Company Ltd.

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Publisher: Cell Press

Cell Biology Molecular Biology Molecular Medicine Medicine(all)

For more information, go to http://www.cell.com/trends/molecular-medicine

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

FinELibin ja Elsevierin sopimuksen perusteella vastaavat kirjoittajat voivat julkaista avoimia artikkeleita ilman APC-maksua (article processing charge) sopimuksen piiriin kuuluvissa Elsevierin Cell Press -lehdissä sopimusvuonna 2025. Julkaisuoikeus koskee hybridilehtiä. Avoimia artikkeleita on rajallinen määrä.
Under FinELib consortium’s agreement with Elsevier, corresponding authors can publish their articles open access without article processing charge (APC) in Cell Press hybrid journals eligible for the agreement during the agreement year 2025. There is a limited number of free open access articles available.

Ohjeita julkaisemiseen FinELibin sivuilla:

Artikkelin julkaiseminen avoimena Elsevierin Cell Press lehdissä

Open Access Publishing in Elsevier’s Cell Press Journals

Publisher: Springer

Artikkelin julkaiseminen avoimena Springer Compact lehdissä

Plant Science Genetics

Tropical Plant Biology covers the most rapidly advancing aspects of tropical plant biology including physiology, evolution, development, cellular and molecular biology, genetics, genomics, genomic ecology, and molecular breeding. It publishes articles of original research, but it also accepts review articles and publishes occasional special issues focused on a single tropical crop species or breakthrough. Information published in this journal guides effort to increase the productivity and quality of tropical plants and preserve the world’s plant diversity. The journal serves as the primary source of newly published information for researchers and professionals in all of the aforementioned areas of tropical science.

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

FinELib-konsortion solmima sopimus Springer Naturen kanssa vuosille 2024-2025 sisältää vastaaville kirjoittajille oikeuden julkaista artikkeleita avoimena ilman lisämaksua Springer Compact -kokoelman hybridilehdissä sopimuskauden aikana. Julkaista voi myös edellisen ja nykyisen sopimuskauden aikana hybridistä täysin avoimeksi muuttuvassa nimekkeessä, joka sisältyy lehtilistaan.
FinELib consortium’s agreement with Springer Nature for the years 2024-2025 includes open access publishing for corresponding authors in Springer's hybrid titles in Compact collection without extra charge during the agreement term. Additionally publishing is possible in titles included in the list that transitioned from hybrid to fully OA during the previous agreement term or do so during the current agreement term.

Ohjeita julkaisemiseen FinELibin sivuilla:

Springer Nature Link Journal Finder

Hae tai selaa Springer Naturen lehtiä sopivan lehden löytämiseksi artikkelisi julkaisemiseen

Open Access Publishing in Springer Compact Journals

Springer Nature Link Journal Finder

Search or browse journals across all of Springer Nature's brands to discover the perfect journal for you

Publisher: SAGE Publications

Cancer Research Medicine(all)

'Tumor Biology' is the Official Journal of the International Society of Oncology and BioMarkers (ISOBM), an international journal publishing original research, mini-reviews and research commentaries on experimental and clinical cancer research. The Journal places special emphasis on articles covering all aspects of tumor markers and tumor targeting, but studies in other areas of clinical and translational cancer research are considered. The Editors also welcome proposals for 'Mini-Reviews' and 'Research Commentaries'. Manuscript categories include Editorials, Research Articles, Reviews, Research Commentaries, and Workshop Reports.

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Publisher: SAGE Publications

Cancer Research Medicine(all)Oncology

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

FinELib-konsortion ja SAGEn välinen sopimus takaa Turun yliopiston henkilökunnalle ja opiskelijoille mahdollisuuden julkaista artikkelinsa avoimena maksutta SAGEn hybridilehdissä ja 27:ssa Full OA -lehdessä. Julkaisuoikeus on rajoittamaton ja koskee vastaavia kirjoittajia. Ohjeita julkaisemiseen FinELibin sivuilla: https://finelib.fi/oa-julkaiseminen-sagen-lehdissa/ The agreement between FinELib consortium and SAGE contains the possibility for the researchers of the participating insitutions to publish their articles open access free of charge in Sage hybrid journals and in 27 Full OA journals. The number of articles is unlimited. OA publishing without extra charge applies to corresponding authors. Instructions on publishing on FinELib's pages: https://finelib.fi/open-access-publishing-in-sage-journals/

Visit journal homepage View author guidelines

Publisher: Galenos Yayinevi

Molecular Medicine Pharmaceutical Science

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

There is no agreement between University of Turku and this journal

Visit Publisher homepage Visit journal homepage View author guidelines View aims and scope

Publisher: National Academy of Sciences of Ukraine

Biochemistry Medicine(all)

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Publisher: Elsevier

Biophysics Radiology Nuclear Medicine and imaging Acoustics and Ultrasonics Radiological and Ultrasound Technology

Ultrasound in Medicine and Biology (UMB) is the official journal of the World Federation for Ultrasound in Medicine and Biology. The journal publishes original contributions on significant advances in clinical diagnostic, interventional and therapeutic applications, new and improved clinical techniques, the physics, engineering and technology of ultrasound in medicine and biology, and the interactions between ultrasound and biological materials, including bioeffects. Extended reviews of subjects of contemporary interest in the field are also published, in addition to occasional editorial articles, clinical and technical notes, letters to the editor and a calendar of forthcoming meetings. It is the aim of the journal fully to meet the information and publication requirements of the clinicians, scientists, engineers and other professionals who constitute the biomedical ultrasonic community.Visit the web site of the World Federation for Ultrasound in Medicine and Biology at: http://www.wfumb.org/ for more information, including affiliated organizations, congresses, newsletters and reports.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

FinELibin ja Elsevierin sopimuksen perusteella vastaavat kirjoittajat voivat julkaista avoimia artikkeleita ilman APC-maksua (article processing charge) sopimuksen piiriin kuuluvissa Elsevierin hybridi- ja hybrideistä gold open access -lehdiksi muuttuneissa lehdissä. Avoimia artikkeleita on sopimuskauden 2024-2025 aikana käytettävissä rajallinen määrä. Turun yliopisto tilaa myös sopimuksen ulkopuolisia lehtiä, joissa on mahdollista julkaista avoimena ilman kirjoittajamaksua. Lisätietoa osoitteesta kirjasto@utu.fi.
Under the agreement between FinELib and Elsevier, corresponding authors can publish open access articles without an APC (article processing charge) in eligible Elsevier hybrid journals and hybrid journals that have transitioned to gold open access. There is a limited number of free open access articles available during the agreement period 2024-2025. University of Turku also subscribes to some additional Elsevier journals that are not included in FinELib consortium agreement. For more information, contact library@utu.fi about publishing article open access without article processing charge (APC).

Ohjeita julkaisemiseen FinELibin sivuilla:

Artikkelin julkaiseminen avoimena Elsevierin lehdissä

Publisher: Taylor and Francis

Structural Biology Pathology and Forensic Medicine

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

There is no agreement between University of Turku and this journal

Visit journal homepage View author guidelines View aims and scope

Publisher: Finlay Ediciones

Molecular Medicine Immunology Immunology and Allergy Drug Discovery

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Publisher: Elsevier

Molecular Medicine Immunology and Microbiology(all)Immunology Medicine(all)Infectious Diseases Public Health, Environmental and Occupational Health veterinary(all)

Vaccine is the journal for those interested in vaccines and vaccination. Submissions to the following categories are welcomed: Human Vaccines - infectious diseases; Human Vaccines - non-infectious diseases; Veterinary Vaccines; Immunology and Animal Models; Vectors, Adjuvants and Delivery Systems; Production, manufacturing; Vaccine Safety; Regulatory, Societal and Legislation Aspects; History of Vaccinology.

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

FinELibin ja Elsevierin sopimuksen perusteella vastaavat kirjoittajat voivat julkaista avoimia artikkeleita ilman APC-maksua (article processing charge) sopimuksen piiriin kuuluvissa Elsevierin hybridi- ja hybrideistä gold open access -lehdiksi muuttuneissa lehdissä. Avoimia artikkeleita on sopimuskauden 2024-2025 aikana käytettävissä rajallinen määrä. Turun yliopisto tilaa myös sopimuksen ulkopuolisia lehtiä, joissa on mahdollista julkaista avoimena ilman kirjoittajamaksua. Lisätietoa osoitteesta kirjasto@utu.fi.
Under the agreement between FinELib and Elsevier, corresponding authors can publish open access articles without an APC (article processing charge) in eligible Elsevier hybrid journals and hybrid journals that have transitioned to gold open access. There is a limited number of free open access articles available during the agreement period 2024-2025. University of Turku also subscribes to some additional Elsevier journals that are not included in FinELib consortium agreement. For more information, contact library@utu.fi about publishing article open access without article processing charge (APC).

Ohjeita julkaisemiseen FinELibin sivuilla:

Artikkelin julkaiseminen avoimena Elsevierin lehdissä

Publisher: Elsevier

Molecular Medicine Physiology Pharmacology

Vascular Pharmacology publishes papers, which contains results of all aspects of biology and pharmacology of the vascular system.Papers are encouraged in basic, translational and clinical aspects of Vascular Biology and Pharmacology, utilizing approaches ranging from molecular biology to integrative physiology. All papers are in English.The Journal publishes review articles which include vascular aspects of thrombosis, inflammation, cell signalling, atherosclerosis, and lipid metabolism.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

FinELibin ja Elsevierin sopimuksen perusteella vastaavat kirjoittajat voivat julkaista avoimia artikkeleita ilman APC-maksua (article processing charge) sopimuksen piiriin kuuluvissa Elsevierin hybridi- ja hybrideistä gold open access -lehdiksi muuttuneissa lehdissä. Avoimia artikkeleita on sopimuskauden 2024-2025 aikana käytettävissä rajallinen määrä. Turun yliopisto tilaa myös sopimuksen ulkopuolisia lehtiä, joissa on mahdollista julkaista avoimena ilman kirjoittajamaksua. Lisätietoa osoitteesta kirjasto@utu.fi.
Under the agreement between FinELib and Elsevier, corresponding authors can publish open access articles without an APC (article processing charge) in eligible Elsevier hybrid journals and hybrid journals that have transitioned to gold open access. There is a limited number of free open access articles available during the agreement period 2024-2025. University of Turku also subscribes to some additional Elsevier journals that are not included in FinELib consortium agreement. For more information, contact library@utu.fi about publishing article open access without article processing charge (APC).

Ohjeita julkaisemiseen FinELibin sivuilla:

Artikkelin julkaiseminen avoimena Elsevierin lehdissä